Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PCSK9 drugs
Pharma
Merck charts long-term path for first PCSK9 pill
The FDA “wanted to use Lipfendra as a cornerstone way to demonstrate what they’re trying to do with” CNPV, Merck’s R&D chief, Dean Li, said.
Angus Liu
Aug 4, 2026 2:38pm
Novartis CEO shrugs off oral PCSK9 threat amid Q2 growth
Jul 21, 2026 10:36am
FDA approves an oral PCSK9 med for 1st time in Merck's Lipfendra
Jul 16, 2026 9:30am
FDA endorses LIB's convenient cholesterol-lowering PCSK9 drug
Dec 15, 2025 11:33am
Fierce Biotech
Merck's PCSK9 drug mounts injectable-like cholesterol reductions
Nov 10, 2025 10:59am
Amgen's Repatha meets the mark in CV primary prevention trial
Oct 2, 2025 11:26am
